Yuan Chunling, Shi Ligen, Sun Zeyu, Xu Fei, Wang Chujun, Shan Jiajing, Hitchens T Kevin, Foley Lesley M, Ye Qing, Chen Jun, Sun Dandan, Hu Xiaoming
Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, PA, USA.
Neurobiol Dis. 2023 Apr;179:106063. doi: 10.1016/j.nbd.2023.106063. Epub 2023 Mar 6.
Recent research highlights the function of regulatory T cells (Tregs) in white matter integrity in CNS diseases. Approaches that expand the number of Tregs have been utilized to improve stroke recovery. However, it remains unclear if Treg augmentation preserves white matter integrity early after stroke or promotes white matter repair. This study evaluates the effect of Treg augmentation on white matter injury and repair after stroke. Adult male C57/BL6 mice randomly received Treg or splenocyte (2 million, iv) transfer 2 h after transient (60 min) middle cerebral artery occlusion (tMCAO). Immunostaining showed improved white matter recovery after tMCAO in Treg-treated mice compared to mice received splenocytes. In another group of mice, IL-2/IL-2 antibody complexes (IL-2/IL-2Ab) or isotype IgG were administered (i.p) for 3 consecutive days starting 6 h after tMCAO, and repeated on day 10, 20 and 30. The IL-2/IL-2Ab treatment boosted the number of Tregs in blood and spleen and increased Treg infiltration into the ischemic brain. Longitudinal in vivo and ex vivo diffusion tensor imaging analysis revealed an increase in fractional anisotropy 28d and 35d, but not 14d, after stroke in IL-2/IL-2Ab-treated mice compared to isotype-treated mice, suggesting a delayed improvement in white matter integrity. IL-2/IL-2Ab also improved sensorimotor functions (rotarod test and adhesive removal test) 35d after stroke. There were correlations between white matter integrity and behavior performance. Immunostaining confirmed the beneficial effects of IL-2/IL-2Ab on white matter structures 35d after tMCAO. IL-2/IL-2Ab treatment starting as late as 5d after stroke still improved white matter integrity 21d after tMCAO, suggesting long-term salutary effects of Tregs on the late-stage tissue repair. We also found that IL-2/IL-2Ab treatment reduced the number of dead/dying OPCs and oligodendrocytes in the brain 3d after tMCAO. To confirm the direct effect of Tregs on remyelination, Tregs were cocultured with lysophosphatidyl choline (LPC)-treated organotypic cerebella. LPC exposure for 17 h induced demyelination in organotypic cultures, followed by gradual spontaneous remyelination upon removal of LPC. Co-culture with Tregs accelerated remyelination in organotypic cultures 7d after LPC. In conclusion, Boosting the number of Tregs protects oligodendrocyte lineage cells early after stroke and promotes long-term white matter repair and functional recovery. IL-2/IL-2Ab represents a feasible approach of Treg expansion for stroke treatment.
近期研究突出了调节性T细胞(Tregs)在中枢神经系统疾病中白质完整性方面的作用。已采用增加Tregs数量的方法来改善中风恢复情况。然而,Treg增加是否能在中风后早期维持白质完整性或促进白质修复仍不清楚。本研究评估了增加Tregs对中风后白质损伤和修复的影响。成年雄性C57/BL6小鼠在短暂性(60分钟)大脑中动脉闭塞(tMCAO)后2小时随机接受Treg或脾细胞(200万,静脉注射)移植。免疫染色显示,与接受脾细胞的小鼠相比,Treg治疗的小鼠在tMCAO后白质恢复情况有所改善。在另一组小鼠中,从tMCAO后6小时开始连续3天腹腔注射白细胞介素-2/白细胞介素-2抗体复合物(IL-2/IL-2Ab)或同型IgG,并在第10、20和30天重复注射。IL-2/IL-2Ab治疗增加了血液和脾脏中Tregs的数量,并增加了Tregs向缺血性脑的浸润。纵向体内和体外扩散张量成像分析显示,与同型治疗的小鼠相比,IL-2/IL-2Ab治疗的小鼠在中风后28天和35天而非14天,各向异性分数增加,表明白质完整性有延迟改善。IL-2/IL-2Ab还改善了中风后35天的感觉运动功能(转棒试验和黏附去除试验)。白质完整性与行为表现之间存在相关性。免疫染色证实了IL-2/IL-2Ab在tMCAO后35天对白质结构的有益作用。中风后5天开始的IL-2/IL-2Ab治疗在tMCAO后21天仍能改善白质完整性,表明Tregs对后期组织修复有长期有益作用。我们还发现,IL-2/IL-2Ab治疗减少了tMCAO后3天大脑中死亡/濒死少突胶质前体细胞和少突胶质细胞的数量。为了证实Tregs对髓鞘再生的直接作用,将Tregs与溶血磷脂酰胆碱(LPC)处理的小脑器官型培养物共培养。LPC暴露17小时可诱导器官型培养物中的脱髓鞘,去除LPC后逐渐自发髓鞘再生。与Tregs共培养可加速LPC处理7天后器官型培养物中的髓鞘再生。总之,增加Tregs的数量可在中风后早期保护少突胶质细胞系细胞,并促进长期白质修复和功能恢复。IL-2/IL-2Ab代表了一种用于中风治疗的可行的Treg扩增方法。